Clinical Trials - The Situation in Belgium in the Light of Recent Case Law in the Netherlands and Germany (Proeven met geneesmiddelen - De situatie in België in het licht van de recente rechtspraak en rechtsleer in Nederland en Duitsland)

PATENT LAW AND MEDICINES, pp. 65-91, G. Van Overwalle, ed., Brussel, Bruylant, 2000

26 Pages Posted: 2 Dec 2010

See all articles by Geertrui Van Overwalle

Geertrui Van Overwalle

KU Leuven - Centre for IT & IP Law (CiTiP)

Date Written: December 1, 2010

Abstract

The paper discusses the scope of patents for medicines, and analyses which acts from third parties, ranging from clinical trials from competitors for improved medicines to generic manufacturers with me-too products, the patent holder can stop.

Note: Downloadable document is in Dutch.

Keywords: Patents, medicines, clinical trials, research exemption

JEL Classification: I18, K11, O32, O34, H51

Suggested Citation

Van Overwalle, Geertrui, Clinical Trials - The Situation in Belgium in the Light of Recent Case Law in the Netherlands and Germany (Proeven met geneesmiddelen - De situatie in België in het licht van de recente rechtspraak en rechtsleer in Nederland en Duitsland) (December 1, 2010). PATENT LAW AND MEDICINES, pp. 65-91, G. Van Overwalle, ed., Brussel, Bruylant, 2000. Available at SSRN: https://ssrn.com/abstract=1718624

Geertrui Van Overwalle (Contact Author)

KU Leuven - Centre for IT & IP Law (CiTiP) ( email )

Sint-Michielsstraat 6 box 3443
Leuven, 3000
Belgium

HOME PAGE: https://www.law.kuleuven.be/citip/en/staff/00015469

Register to save articles to
your library

Register

Paper statistics

Downloads
45
Abstract Views
384
PlumX Metrics